Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
89,506,929
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
20,284,874
-
Shares change
-
-291,381
-
Total reported value, excl. options
-
$117,447,374
-
Value change
-
-$1,995,259
-
Put/Call ratio
-
13.62%
-
Number of buys
-
13
-
Number of sells
-
-15
-
Price
-
$5.79
Significant Holders of Milestone Pharmaceuticals Inc. - Common Stock (MIST) as of Q1 2021
44 filings reported holding MIST - Milestone Pharmaceuticals Inc. - Common Stock as of Q1 2021.
Milestone Pharmaceuticals Inc. - Common Stock (MIST) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20,284,874 shares
of 89,506,929 outstanding shares and own 22.66% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (4,315,102 shares), ORBIMED ADVISORS LLC (2,583,821 shares), BOXER CAPITAL, LLC (2,572,194 shares), Novo Holdings A/S (2,530,585 shares), RA CAPITAL MANAGEMENT, L.P. (2,246,503 shares), Ikarian Capital, LLC (1,836,545 shares), SUVRETTA CAPITAL MANAGEMENT, LLC (851,291 shares), MORGAN STANLEY (850,998 shares), MILLENNIUM MANAGEMENT LLC (717,797 shares), and PURA VIDA INVESTMENTS, LLC (467,640 shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.